Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


HRT drug Gina 10mcg given green light for POM to P switch

Community pharmacists will soon be able to dispense one brand of estradiol hemihydrate vaginal tablets without a prescription.

Following the outcome of a Medicines and Healthcare products Regulatory Agency (MHRA) consultation, pharmacists will be able to dispense hormone replacement therapy (HRT) drug Gina 10mcg without prescription come September.

The consultation, which ran from February 2 to February 23 this year, received an “unprecedented” 1,229 responses, showing “overwhelming” support for the reclassification, according to the MHRA.


Read more: HRT drug Gina 10mcg could become P medicine following MHRA consultation


Almost 9 in 10 (88%) supported the proposal, while 7% did not and 5% were unsure.

From September, Gina 10mcg will become available over the counter to those aged 50 and above “who have not had a period for at least one year”.

It follows license holder Novo Nordisk's successful application to reclassify the product as a pharmacy (P) medicine and marks the MHRA’s first reclassification of a hormone replacement therapy (HRT) product.


Reclassification will “improve access”


Consultation respondents came out in favour of Gina’s reclassification as a P med on the grounds that being able to buy the 10mcg tablets from a pharmacy without a prescription would improve overall access to HRT treatment and “free up GP appointments for other issues”.

While demand for HRT products has surged dramatically over recent months, stock levels have fluctuated.

The Department of Health and Social Care issued a slew of serious shortage protocols for HRT products in May to give pharmacy teams “different options” when faced with “significant ongoing disruption” to stock levels.


Read more: Pharma company to boost HRT production with new manufacturing site


Although many consultation respondents raised concerns that having to pay for Gina 10mcg tablets in a pharmacy “would introduce a barrier to access for [patients] unable to afford” it, the MHRA noted that the drug and other forms of HRT treatment would still be available through the NHS via a prescription from a GP.

The MHRA will provide pharmacy training materials to pharmacists, including a pharmacy guide and a pharmacy checklist, to ensure the drug is suitably supplied.

Related Content


Pharmacy Manager

Apply Now
Latest News & Analysis
See All



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts